🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A fun debate with ⁦jim catto⁩ ⁦Ashish M. Kamat, MD, MBBS⁩ let’s work to improve TURBT and clinical staging Imaging We are way behind prostate ⁦Photocure⁩ ⁦BCANY⁩ #gdsfellows #bladdercancer ⁦NYU Langone Urology⁩ jmt.nyumc.org/Pages/OOCM_Tra…

SeaGen EV-104 intravesical Enfortumab Vedotin for HR NMIBC NYULangone First site now open Great potential treatment with novel MOA #gdsfellows NYU Langone Urology BCAN NCT Chapter Ashish M. Kamat, MD, MBBS

Great sessions FDA workshop Option 3 clinical trial design for novel agents in HR BCG naive is critical for innovation biotech and big pharma can accrue to these trials quickly and move on from BCG #gdsfellows Ashish M. Kamat, MD, MBBS Trinity J. Bivalacqua BCAN NCT Chapter NYU Langone Urology

Bladder Cancer landscape rapidly changing for the benefit of our patients #gdsfellows ⁦NYU Langone Urology⁩ ⁦NYU Langone Health⁩ ⁦Bladder Cancer Advocacy Network⁩ medpagetoday.com/clinical-chall…

In significant number of patients ileal conduit performed well is the best option, patient selection for continent diversion is critical NYU Langone Urology #gdsfellows #bladdercancer BCAN NCT Chapter Sia Daneshmand, M.D. Ashish M. Kamat, MD, MBBS

urldefense.com/v3/__https:/ww…$

files.aievolution.com/prd/nyu1601/te… ⁦Perlmutter Cancer Center at NYU Langone Health⁩ ⁦NYU Langone Urology⁩ #bladdercancer #gdsfellows ⁦Ashish M. Kamat, MD, MBBS⁩ ⁦Joshua Meeks⁩ ⁦bcan

Watching The Tourist HBOmax Lead detective depicted easily emptying his ileal conduit never saw that in Drama before cystectomy IC patients live fully active lives #gdsfellows #bladdercancer BCAN NCT Chapter Perlmutter Cancer Center at NYU Langone Health NYU Langone Urology

Neoantigen Cancer Vaccines Precision ImmunoOncologyReview #gdsfellows Perlmutter Cancer Center at NYU Langone Health NYU Langone Urology BCAN NCT Chapter tandfonline.com/doi/epub/10.10…

Still many unresolved issues NMIBC Multiple studies ongoing with novel agents We need to choose a few lanes to make progress #gdsfellows Ashish M. Kamat, MD, MBBS Perlmutter Cancer Center at NYU Langone Health NYU Langone Urology Bernie Bochner, MD BCAN NCT Chapter

urldefense.com/v3/__https://w…$ this was fun NYU Langone Urology #gdsfelliws Perlmutter Cancer Center at NYU Langone Health bcan

tandfonline.com/doi/epdf/10.10… #gdsfellows NYU Langone Urology Perlmutter Cancer Center at NYU Langone Health #bladdercancer Ashish M. Kamat, MD, MBBS UroToday.com

urldefense.com/v3/__https://r…$ Neobladder for bladder cancer patients is successful Need to strive for innovative improvements #gdsfellows Stephanie Chisolm, PhD NYU Langone Urology Perlmutter Cancer Center at NYU Langone Health

Targeting bladder cancer with precision immunotherapy vaccine may preserve the bladder lnkd.in/ewFUFUHP #gdsfellows Stephanie Chisolm, PhD NYU Langone Urology Perlmutter Cancer Center at NYU Langone Health EECherullo

In this exclusive video, Gary Steinberg, from the Department of #Urology at Perlmutter Cancer Center at NYU Langone Health, discusses multiple studies on therapies for non-muscle-invasive #bladdercancer and their implications for clinical practice. bit.ly/3mg7zqj

Intermediate risk #NMIBC: Surveillance and treatment challenges. #AUA23 debate moderated by Stephen B. Williams, MD, MBA, MS, FACHE along with Paolo Gontero and Gary Steinberg. Written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3LLE4Hc Amer. Urol. Assn.

Updated results from #CORE1 using pembro + cretostimogene (cg0070) in BCG unresponsive CIS 👉 Overall CR = 85% (29/34) 👉CR @ 12 months = 68% (17/25) 👉AE profile similar to monotherapy trials Gary Steinberg Ashish M. Kamat, MD, MBBS Trinity J. Bivalacqua CG Oncology, Inc. onclive.com/view/phase-2-d…

Lots of discussion after recent SUO match .. Should Research Year be optional for SUO accredited fellowships ?

NYC is great but very glad to be back sweet home Chicago! I start at Rush July 10th in the cancer center and dept of Urology #gdsfellows #bladdercancer bcan

futuremedicine.com/doi/10.2217/FO… Recent review re: CREST TRIAL HR BCG NAIVE NMIBC #gdsfellows Rush Urology RUSH Cancer Center Ashish M. Kamat, MD, MBBS #bladdercancer